Edwards Lifesciences Corporation
Income Statement
| Line Item | FY2009 | FY2008 |
|---|---|---|
| Revenue | $1.32B | $1.24B |
| Cost of Revenue | $399.1M | $419.6M |
| Gross Profit | $922.3M | $818.1M |
| Gross Margin | 69.8% | 66.1% |
| Operating Expenses | ||
| Research & Development | $175.5M | $139.2M |
| SG&A Expense | $508.8M | $480.6M |
| Operating Income | $307.1M | $171.6M |
| Operating Margin | 23.2% | 13.9% |
| Interest Expense | $2.7M | $7.2M |
| Pretax Income | $304.4M | $164.4M |
| Income Tax Expense | $75.3M | $35.5M |
| Net Income | $229.1M | $128.9M |
| Net Margin | 17.3% | 10.4% |
| EPS (Basic) | $0.68 | $0.38 |
| EPS (Diluted) | $0.65 | $0.37 |
| Shares Outstanding (Basic) | 337.5M | 335.1M |
| Shares Outstanding (Diluted) | 352.5M | 357.6M |
| Dividends Per Share | — | — |